Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Euro zone stocks to outshine Britain's FTSE if economy recovers

Fri, 31st Jan 2014 14:48

* Global economy on road to recovery

* Germany, Spain, Italy indexes have big cyclical exposure

* UK's FTSE laden with defensives, low beta energy stocks

By Tricia Wright

LONDON, Jan 31 (Reuters) - The global economy is on themend, and for equity investors betting on a recovery throughEurope's share indexes, Germany, Spain and Italy are good plays,while Britain is best avoided in spite of its rude economichealth.

Investing by buying an index tracker fund is a popularstrategy as it can be cheaper and require less research thanselecting a basket of shares.

With the global economy set to grow 3.6 percent this yearcompared with 2.9 percent in 2013, according to a Reuters poll,and signs that the euro zone is gradually improving, aone-and-a-half year rally in European stocks still has some wayto run, analysts say.

Based on recovery prospects alone, Britain looks like a goodbet for investors, as it is the most rapidly improving economyin Western Europe.

But, drill deeper, and its blue-chip FTSE 100 share index has a smaller proportion of cyclical stocks, or sharesmost exposed to the economic cycle, than any other majorEuropean index, at just 65 percent, according to Reuterscalculations.

In contrast, the German DAX, with a highconcentration of auto and chemical stocks, is 81 percentcyclicals.

The DAX hit a record high this month but analysts say solidearnings forecasts for German blue chips means it is stillattractive.

Profits in Germany are seen rising 13.2 percent in the nexttwo years, against a 10.2 percent rise over that period forUK-listed companies, according to StarMine's SmartEstimates -which use the top analysts' forecasts based on accuracy andtimeliness.

"Germany - it outperforms like clockwork when the globaleconomy picks up," said Peter Sullivan, head of European equitystrategy at HSBC, citing it as one of his top picks.

German car parts and tyre maker Continental andautomaker Daimler have rallied around 36 percent and18 percent over the last six months, respectively, against a 13percent rise in the benchmark, while chemical heavyweights BASF and Bayer have gained 18 percent and 17percent respectively.

Spain and Italy's main indexes also offer higher cyclicalexposure than Britain, and within that are likely to see extrabenefits from their high weightings in financials, analysts say.

As the economy recovers, banks' bad debt exposure goes down,and real estate markets eventually pick up, also working in thesector's favour.

"Italy and Spain have come out of recession and willprobably deliver the biggest ... (shift) from a very low levelof growth to a higher level, and a very significant pick-up inearnings as well," JPMorgan analyst Emmanuel Cau, said.

"Banks, which are the biggest weight, will be the driver ofthe upside (in Spain and Italy's equity markets)."

On Spain's IBEX, Bankinter and BancoPopular have leapt around 60 percent over the last sixmonths, compared with an 18 percent rise on the benchmark.

Italian banks UBI Banca and BP Emilia jumped around 70 percent and 50 percent over the period, againsta 17 percent rise on Milan's FTSE MIB.

Yet Banco Popular or UBI Banca, for example, are still 75percent and 50 percent respectively below levels seen before theeuro zone crisis erupted in late 2009.

Banks account for 32 percent of the IBEX and 25 percent ofthe MIB. In contrast, a large chunk of the FTSE 100's cyclicalexposure comes from a 17 percent weighting of low 'beta' energystocks, which stand to gain less when equity markets rise.

Mining shares, whose weakness in 2013 has extended into thisyear, account for another 8 percent weighting in the FTSE andtheir low earnings growth prospects have helped cap the overalloutlook for UK equities.

SmartEstimate's projected profit growth of 10.2 percent forUK companies over the next two years is below the average forDeveloped Europe at 13.6 percent, and far behind Spain andItaly, where earnings are set to grow by more than 20 percent.

That means equity markets in Spain and Italy still lookcheap even if valuations for the IBEX and the FTSE MIB haverisen to 15.5 times and 13.3 times respectively on a 12-monthforward price/earnings basis - against their 10-year averages of11.7 times and 10.4 times.

France's CAC index has average earnings growthpotential, but it has one of the lowest proportions of cyclicalstocks among Europe's major indexes, at 68 percent.

UK CAUTION

Equity strategists at UBS, seeking to lift their cyclicalexposure, recently downgraded their view on the UK to "smallunderweight" relative to their benchmark, preferring Japan andcontinental Europe.

The bank is also "underweight" defensive consumer staples,which account for more than 14 percent of the FTSE 100.

This dwarfs the IBEX's exposure, at 1.3 percent, as well asthe DAX and FTSE MIB at around 5 percent each.

Defensive stocks, whose earnings are reliable because theysell essentials, include Unilever, whose brands includeLipton tea and Dove soap, and drugmaker GlaxoSmithKline.

"We're certainly more cautious on the UK market compared toother European markets given the make-up of the index - thereare greater defensive plays in there compared to Europeanmarkets," Barclays strategist Henk Potts, said.

"Better news on growth, a continuation of reforms andaccommodative European Central Bank policy should create astronger earnings growth profile for European companies," hesaid.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.